CDH5 and ischemic stroke: VE-Cadherin+ (CDH5+) AJs showed a similar behavior to eGFP::Claudin-5+ TJs (90–95% correlation) at the BBB after ischemic stroke with no significant differences observed between two genotypes (Figure S3).